To what extent are BRCA mutation carriers and their partners in the Netherlands aware about preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND) as reproductive options and what is their attitude towards these options?
Introduction
Women who have a mutation in one of the breast cancer genes BRCA1 or BRCA2 face elevated risks of 27-57% of developing breast cancer and 6-40% of developing ovarian cancer by the age of 70 (Chen and Parmigiani, 2007; Brohet et al., 2014) . In the Netherlands, 13 000 women are diagnosed with breast cancer and~1400 are diagnosed with ovarian cancer every year. Of the note ,5-10% of the cases are caused by a genetic mutation (HEBON, 2016) . Preventive options are limited to chemoprevention and prophylactic surgery and although therapeutic options are available, average age prospects are reduced due to a relatively early age of onset (Lux et al., 2006) .
Since hereditary breast and ovarian cancer (HBOC) is an autosomal dominant predisposition, carriers have a 50% risk of passing on the mutation to their offspring. Couples who want to have a child biologically related to both partners have three reproductive options: (i) Conception without BRCA diagnosis, and accept the risk of passing on the BRCA mutation, (ii) Prenatal Diagnosis (PND), i.e. BRCA diagnosis during pregnancy and possible termination of pregnancy (TOP) in case of a female carrier and (iii) Preimplantation Genetic Diagnosis (PGD), i.e. selection of IVF/ICSI embryo's free of the familial BRCA mutation before implantation in the uterus.
The decision-making process considering these reproductive options has proven to be demanding for couples with HBOC. The emotional impact of the decision can be long lasting and significant, as particularly non-users of PGD and PND may be confronted with feelings of doubt and guilt up to years after the decision has been made (Derks-Smeets et al., 2014) .
In the Netherlands, PGD was introduced in 1995 and after nationwide political and ethical discussions, approved for late onset inherited cancer predisposition syndromes in 2008. Nowadays, HBOC is one of the most frequent indications for PGD in the Maastricht University Medical Centre+ (Maastricht UMC+), the only licensed PGD centre in the Netherlands. Of the couples with BRCA that seek reproductive counselling about PGD,~60% opt for PGD (MUMC+, Department of Clinical Genetics, 2016) . PND for HBOC is available on a case-by-case basis in some University Medical Centres and both PGD and PND treatments are covered by the Dutch health insurance system.
The available literature suggests that the rapid development of PGD may have outpaced the awareness of this reproductive option among couples with HBOC. In 2012, a meta-analysis was published reviewing 13 studies (conducted in the USA, several European countries and Israel) about PGD awareness and acceptability among persons with hereditary cancer, showing that awareness of PGD was low (30-35%), whereas acceptability was relatively high (71%) (Quinn et al., 2012) . Knowledge about PGD has not been properly measured in the studies to date, since its assessment generally pertains to mere awareness (i.e. having heard of…) instead of measuring actual PGD understanding. Moreover, among the studies that focussed on HBOC there was substantial variation in study populations: several included respondents for whom a genetic mutation had not been confirmed (Fortuny et al., 2009; Vadaparampil et al, 2009) , many included only men or women (Menon et al., 2007; Vadaparampil et al., 2009; Quinn et al., 2010) , few specifically included participants of reproductive age (Julian-Reynier et al., 2012; Staton et al., 2008) and/or investigated small samples sizes (<80) (Menon et al, 2007; Fortuny et al., 2009) . Furthermore, the studies differed considerably in information provision about PGD, which was often scarce, before assessing PGD acceptability. These issues may have caused bias, as they are likely to influence PGD awareness, knowledge and attitude. Moreover, most of these studies exclusively considered the views of mutation carriers and missed out on the valuable and influential perspective of the noncarrier partners.
An overview of awareness, knowledge, acceptability and experiences regarding PND for HBOC is currently lacking in the literature. In many European countries, there are no clear regulations concerning PND for HBOC and despite its technical feasibility, it is generally not often performed (Offit et al., 2006; Ormondroyd et al., 2012) . This may be related to (un)awareness and/or (un)acceptability of this reproductive option and should be investigated.
When viewing (reproductive) decision-making from a socialcognitive perspective, the decision-making process parallels behaviour change. Several well-known theories and models in this field propose various phases in which change takes place, for example the Precaution Adoption Process Model (PAPM) (Weinstein and Lyon, 1998) and the Transtheoretical Model of Behaviour Change (TTM) (Prochaska, 2008) . These theories describe several stages to change a health behaviour and show that the initial step towards well informed decision-making is becoming aware of the available options, and subsequently gaining knowledge about these options. A couple that is not aware of PGD or PND simply cannot consider using it. Only when being completely informed about the procedures, risks and benefits of the options, a couple can weigh the pros and cons of each option and make their personally best suitable reproductive choice. Therefore, information provision about PGD and PND for HBOC should be optimized. This can be realized by attuning this information provision to different socio-demographic subgroups. We investigated PGD and PND awareness, knowledge and acceptability as well as personal intention to use either of these options and their demographic and medical correlates, among BRCA carriers and their partners in the Netherlands, who were well informed about the implications of these options (i.e. given written information about PGD and PND). By gaining insight into this, guidance and support during the reproductive decision-making process for couples with HBOC can be optimized and adequately tailored to subgroups.
Materials and Methods

Participants and procedures
Carriers of a BRCA1 or BRCA2 mutation and partners of carriers were invited to complete an online questionnaire anonymously between July 2012 and June 2013. Inclusion criteria were (i) having a confirmed BRCA1/ 2 mutation or a partner with a confirmed BRCA1/2 mutation and (ii) sufficient knowledge of the Dutch language. Recruitment strategies were aimed at persons in their reproductive age but this was not an inclusion criterion. Two different recruitment strategies were used. For the first strategy, announcements of the study were placed on several informative websites regarding breast and ovarian cancer, digital communities of patient organizations for HBOC and in the digital newsletter of the Dutch patient organization for HBOC. Persons interested in participating could follow a link in the announcement, which led them to an introduction to the questionnaire providing detailed information about the study and contact details of the researcher in case of any additional questions. It was clearly stated that informed consent was given by initiating the questionnaire. For the second recruitment strategy, eligible couples were identified from the databases of two Dutch Clinical Genetics departments (Maastricht University Medical Centre+ (MUMC+) and Radboud University Medical Centre (Radboudumc)). Individuals with a BRCA1/2 mutation, diagnosed between 2008 (when PGD became available for HBOC in the Netherlands) and 2013 were selected from the databases and received an invitational letter accompanied by information about the study, including a link to the online questionnaire. The two strategies were aimed at both BRCA carriers and partners of carriers without the necessity to participate as a couple. Procedures were approved by the local medical ethics committee of the MUMC+.
Questionnaire
The questionnaire was based on a literature search and the results of a focus group study about decision-making on PGD and PND among couples with HBOC (Derks-Smeets et al., 2014) . Before finalization, the questionnaire was pre-tested by two BRCA carriers (one male, one female) and their partners, which resulted in minor adaptations.
The four main outcome variables concerned: (i) whether the participant was aware of the possibility of PGD or PND for HBOC before filling in the questionnaire (yes/no; two questions), (ii) the level of knowledge of PGD for HBOC among participants who were previously aware of PGD (nine questions), (iii) whether the participant regarded PGD or PND for HBOC acceptable (1 = totally disagree, 5 = totally agree; two questions) and (iv) whether the participant would personally consider using PGD or PND for HBOC or for another serious genetic condition (1 = no, definitely not, 5 = yes, definitely; two questions). PGD knowledge was measured with seven closed-ended questions (true/false/not sure) and two open ended questions (recoded into correct answer = 1, all other answers = 0). These nine items were transformed into a scale with a Cronbach's α of 0.72.
In addition, current child wish (1 = no (not anymore)/2 = maybe, not sure/3 = yes, in the future but not at this moment/4 = yes, trying to get pregnant/5 = yes, currently pregnant), perceived seriousness of breastand ovarian cancer (5-item scale) and the preferred reproductive option at present time (conception without BRCA diagnosis/PGD/PND/donor/ adoption/refrain from children) were assessed.
Demographic factors of interest were age, gender, educational level (1 = no education completed, 8 = university level), partner status (partner/no partner), religiosity (yes/no) and ethnicity (Dutch/non-Dutch). Medical factors included carrier status (carrier/partner of carrier), mutation type (BRCA1/BRCA2), personal history of breast/ovarian cancer (yes/ no), history of breast/ovarian cancer among first degree family members (categorized into: <3/≥3), medical indication for IVF (yes/no), previous pregnancy (yes/no) and child(ren) (yes (how many)/no). After measuring awareness and knowledge and before assessing acceptability, detailed information about PGD and PND procedures and risks was provided, based on the information given during a reproductive consultation by a clinical geneticist. An overview of the main questionnaire items is provided in Table I .
Data analysis
Collected data were automatically stored in SPSS 19.0 and then analysed. Descriptive statistics were used for an overview of PGD and PND awareness, knowledge, acceptability and personal intention to use these options among the general group and within socio-demographic subgroups. Due to insufficient variation within the predictor ethnicity (Table II) , this variable was not included in further analyses. Pearson correlations, independent sample t-tests and Pearson chi-square tests were used to assess correlates of demographic and medical factors with the four outcomes of interest. The non-parametric Mann Whitney U-tests or Spearman correlations were used for analyses with ordinal variables. For multivariate analyses, a linear or logistic regression model (enter method) was built by including only the independent variables that showed significant associations with the outcome variables in the bivariate analyses. A significant outcome was defined when P < 0.05.
To determine which proportion of the sample was of reproductive age (18-40 years) we combined the age of all female respondents with the age of the female partners of the male respondents and calculated the proportion that was between 18 and 40 years old.
Post hoc analyses were conducted in order to check whether the recruitment strategy (online versus clinical genetics centre) significantly influenced the main variables.
Results
Participants' characteristics
The survey was completed by 191 eligible participants of which the majority (88%) was recruited through the online recruitment strategy.
The remainder (12%) was invited by the Clinical Genetics departments. Recruitment strategy (online versus clinical genetics centre) did not significantly influence the main variables. Table II provides an overview of participants' characteristics.
Awareness of PGD and PND for HBOC
Of the total sample 66% of respondents were aware of PGD for BRCA, with a higher awareness rate (84%) among respondents with a child wish. Descriptive statistics are shown in Table III . Bivariate analyses (Table IV) showed that younger persons, those with a higher educational level, with a more immediate child wish and those without children were more often aware of PGD for HBOC. Multivariate analyses by means of logistic regression (Table V) confirmed that respondents with a higher educational level and those with a more immediate child wish were more likely to be aware of PGD for HBOC.
Awareness of PND for HBOC correlated with younger age, higher educational level, a more immediate child wish, being childless, having more family members with cancer and with a BRCA1 mutation. Multivariate analyses confirmed that the higher educated were more likely to be aware of PND for HBOC.
Knowledge about PGD for HBOC
The mean level of knowledge about PGD for HBOC, among those who were aware of PGD for HBOC, on a 9-point scale was 5.5 (SD = 2.4). Bivariate analyses showed that knowledge about PGD positively correlated with educational level, a more immediate child wish and with being childless (Table IV) . Multivariate analyses by means of linear regression confirmed that a more immediate child wish was associated with a higher level of knowledge about PGD for HBOC (Table VI) .
Acceptability of PGD and PND for HBOCs
The mean acceptability score of PGD for HBOC was 4.1 (SD = 0.9) on a 5-point scale. Bivariate analyses showed that acceptability of PGD for HBOC positively correlated with educational level, being childless, having a personal history of cancer, previous awareness of PGD for HBOC and with knowledge about PGD for HBOC (Table IV) . Multivariate analyses confirmed that respondents with a higher level of knowledge about PGD for HBOC were more likely to consider PGD for HBOC acceptable (Table VI) With PGD for HBOC in the Netherlands the embryo is also screened for other predispositions than HBOC True(1)-false(0)-not sure (0) Hormone-use by the woman is not always necessary for a PGD treatment True(1)-false(0)-not sure (0) PGD takes place before the woman is pregnant
When a couple is normally fertile, the chance of a pregnancy after a PGD treatment is nearly 100% True(1)-false(0)-not sure (0) What is a woman's maximum age for PGD in the Regarding PND for HBOC, the mean acceptability score was 2.7 (SD = 1.2) on a 5-point scale. Older age and being a partner (as opposed to being a carrier) positively correlated with a higher acceptability of PND for HBOC (Table IV) . Multivariate analyses confirmed that partners were more likely to consider PND for HBOC acceptable than carriers (Table VI) .
Personal consideration to use PGD and PND for HBOC
Mean scores for consideration to use PGD for HBOC or to use PGD for another serious genetic disease were 3.1 (SD = 1.4) and 3.6 (SD = 1.0) on a 5-point scale, respectively. A significantly higher proportion of participants would consider using PGD for another serious genetic condition than HBOC (t = −13.19, P < 0.000). Consideration to use PGD for HBOC positively correlated with personal history of cancer and perceived seriousness of breast-and ovarian cancer, whereas it negatively correlated with being religious and having children (Table IV) . Multivariate analyses by means of linear regression confirmed that respondents with a personal history of cancer and with a higher perceived seriousness of breast-and ovarian cancer were more likely to consider using PGD for HBOC (Table VI) .
Mean scores for consideration to use PND for HBOC or to use PND for another serious genetic disease were 2.4 (SD = 1.3) and 3.4 (SD = 1.1) on a 5-point scale, respectively. Again, a significantly higher proportion of participants would consider using PND for another serious genetic condition than HBOC (t = −16.67, P < 0.000). Consideration to use PND for HBOC positively correlated with age, a BRCA1 mutation, personal history of cancer, having a more immediate child wish and perceived seriousness of breast-and ovarian cancer, whereas it negatively correlated with educational level (Table IV) . Multivariate analysis showed that participants with a personal history of cancer and those with a higher perceived seriousness of breast-and ovarian cancer were more likely to consider using PND for HBOC (Table VI) .
Discussion
Reproductive decision-making can be challenging for couples with HBOC to such an extent that some couples experience a negative psychological impact for many years after making their reproductive choice (Derks-Smeets et al., 2014). To limit this negative psychological impact in the future, it is of great importance that couples are enabled to make a well informed and balanced decision. behaviour change (e.g. PAPM, TTM), couples first need to be made aware of the available options. Next, they need to gain knowledge about these options and to start contemplating (Weinstein and Lyon, 1998; Prochaska, 2008) . As stated before, a couple can only make their personally best suitable reproductive choice when being completely informed. This study shows that awareness of PGD (66%) and PND (61%) for HBOC in the Netherlands (84% and 78% for those with a child wish) is relatively high compared to the 35% awareness of PGD in other Western countries (Quinn et al., 2012) , although this still leaves one in five of the potential users unaware. A possible explanation for this raise in awareness is that PGD techniques and regulations have been rapidly evolving the last few years, which may have caused an overall increase in PGD awareness. Moreover, persons who responded to the study may be more aware of PGD than those who did not. It is possible that those motivated enough to respond were more likely to be motivated to seek information about their reproductive options. Both educational level and having a more immediate child wish increased the likelihood of being aware of PGD and PND. The positive relationship between awareness and a child wish, however, might run both ways: (i) couples with a more immediate child wish may more often be aware of PGD and PND due to a higher motivation to seek information about their reproductive options or (ii) couples who are unaware of PGD and PND may be more likely to refrain from their child wish, unwilling to take the risk of passing on the *BRCA mutation since they are unaware of options that can prevent this. Although this last scenario is unlikely from a clinical experience point of view, given that a limited number of couples with a confirmed BRCA mutation choose to use PGD or PND when made aware of these possibilities, scientific data about this are still lacking and it would be a relevant topic for further study. Due to the cross-sectional design of this study we can merely detect the association and not its causality. Nevertheless, acceptability of PGD for HBOC is high (80%) and this corresponds with results from previous studies (Kastrinos et al., 2007 , Menon et al., 2007 .
We found that both acceptability and personal consideration are significantly higher for PGD (80% and 39%) than for PND (26% and 20%) and noticed a large gap between acceptability and personal consideration to use PGD, whereas this gap was considerably smaller for PND. This may be explained by the fact that most couples with HBOC consider PGD as their best option from a moral point of view, but in comparison with their perceived seriousness of HBOC they often consider it a highly burdensome, time-consuming treatment with a relatively low chance of success as was shown by a qualitative study by DerksSmeets et al. (2014) . In that study, all couples with HBOC who considered PND an acceptable option indeed chose this option, whereas PGD was used by less than half of the couples who considered this acceptable. Moreover, 14% of women in the present study were not of reproductive age and 48% did not have a current child wish. This Awareness PGD Awareness PND Knowledge PGD Acceptability PGD Acceptability PND Consideration PGD Consideration PND P (Pearson's r / X 2 / t / Mann Whitney U / Spearman's r s )
Demographic factors
Gender ( may have caused a lack of personal relevance concerning consideration to use PGD or PND for these participants and may partially explain the gap between PGD acceptability and consideration to use PGD, although this does not explain the difference between PGD and PND. In addition, we noticed that couples' consideration to use PGD or PND was significantly higher for other serious genetic conditions than for HBOC (PGD: 58% versus 39%, PND: 52% versus 20%). This indicates that moral and ethical reservations about using these reproductive techniques for late onset cancer predispositions such as HBOC are not limited to the general public but also play a role within the group of potential users. However, we did not specify any further characteristics of 'another serious genetic condition', which suggests that the comparison condition may have differed among respondents. This study also showed that respondents with more knowledge about PGD are more likely to consider PGD for HBOC acceptable, which is in concordance with the results of Meister et al. (2005) . This could be an indication of the general misconceptions about PGD among persons with little knowledge, concerning the impression of creating a 'designer baby' previously described by Roberts and Franklin (2004) . Due to the commonly displayed stereotype of runaway technology, persons with little knowledge about PGD may believe that the selection of embryos is not solely focused on a serious genetic mutation but can additionally be used to select gender or even traits such as eye-and hair-colour which may negatively influence PGD acceptability. Hence, more knowledge about the actual possibilities and limitations of PGD often leads to more acceptability.
When investigating the acceptability of PND for HBOC, we found that partners more often consider this acceptable than BRCA carriers. This is also described in previous qualitative studies as the quandary of carriers who wish to prevent further transmission of their genetic mutation but at the same time, when considering TOP, feeling guilty about denying themselves and family members with the mutation the right to live (Lodder et al., 2000; Ormondroyd et al. 2012) . It should be mentioned though, that 93% of the carriers in the current study were women, and women are known to consider TOP for HBOC less acceptable than men (Julian-Reynier et al., 2012) . In this light, it should also be considered that the technical procedure concerning TOP is performed on the woman's body, which might be an extra disadvantage of PND for women as opposed to men.
Furthermore, we identified several associations of participants' demographic and medical characteristics with awareness, knowledge, acceptability and personal intention to use PGD or PND. Respondents with a higher educational level were more often aware of PGD and PND, and PGD awareness and knowledge were higher among those with a more immediate child wish. Persons with a higher educational level and a more immediate child wish might be more prone to search for information about their reproductive options. Health information seeking behaviour is generally related to socioeconomic status, and health problems (in this case, the genetic predisposition combined with an urgent child wish) are identified as the primary motivations for health information seeking (Ledford et al., 2015; Li et al., 2015) . An association between socio-economic status and PGD awareness has also been reported by Rich et al. (2014) .
Finally, respondents were more inclined to consider PGD as well as PND for HBOC when having a personal history of cancer and when having a higher perceived seriousness of breast-and ovarian cancer. This is in line with the findings from prior research that couples with HBOC base their decision whether to interfere in the reproductive process on their perceived seriousness of breast-and ovarian cancer (Fortuny et al., 2009; Derks-Smeets et al., 2014) and that negative genetic and reproductive experiences positively influence attitude, acceptability and willingness to use PGD (Karatas et al., 2010) .
Limitations
When interpreting the results of this study, several limitations need to be taken into account.
The response rate (23%) of participants invited by the clinical genetics departments was low. This was probably related to a simultaneous study using a similar recruitment strategy within the same target group, which may have resulted in selection bias. Second, PGD knowledge was measured with an instrument that had not yet been validated. However, to our understanding there is no validated instrument to measure PGD knowledge available at this moment. In comparison to other studies that claim to have measured PGD knowledge by merely assessing PGD awareness, the measure used in this study may be a solid starting point to get insight into what eligible couples actually know about PGD. A third limitation may be that although we consider the likelihood of both members of a couple taking part in the study as small, we have not explicitly assessed this and we can, therefore, not exclude the possibility of dependence of observations in the sample. In the hypothesis testing no correction was made for multiple comparisons. Moreover, a minority (16%) was just passed reproductive age (defined as >40 years female age), which may have caused bias due to the lack of personal relevance of some questions. However, since PGD was introduced in the Netherlands in 1995, these participants may have been informed about PGD (whether or not during their reproductive years), which is relevant information for this study. Finally, the cross-sectional design of this study limits us from drawing any causal conclusions.
Implications for practice
Although awareness of both PGD and PND is relatively high among Dutch persons with HBOC who have a child wish, still one in five is unaware and may, therefore, not be able to make a well informed reproductive choice. To some extent, awareness and knowledge concerning PGD and PND are related to social-cognitive and even demographic factors, which should not be desirable. This study showed that persons with a higher educational level are more likely to be aware of PGD and PND, and that awareness and knowledge of PGD and PND can influence the acceptability of these reproductive options. This makes optimization of information provision about these options, attuned to different socio-demographic subgroups indispensable. Main information channels about HBOC should be identified and updated with comprehensible information about PGD and PND for all educational levels. Moreover, PGD and PND awareness, knowledge and acceptability of health professionals involved in the field of HBOC should be investigated and they should be educated in identifying patients who are eligible for these reproductive options and in providing initial information about these options. However, providing detailed information about PGD and PND should remain the responsibility of the clinical geneticist.
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